FOSAMAX

Brand name authorized in: Austria Brazil Canada Germany Spain France Hong Kong Ireland Netherlands Singapore United Kingdom United States

Active ingredients

The drug FOSAMAX contains one active pharmaceutical ingredient (API):

1 Alendronate sodium trihydrate
UNII 2UY4M2U3RA - ALENDRONATE SODIUM

Alendronic acid is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation. The bone formed during treatment with alendronic acid is of normal quality.

Read about Alendronic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
M05BA04
Alendronic acid
M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA04

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
FOSAMAX Once Weekly Tablets
Summary of product characteristics (SPC)
UK
Fosamax
Summary of product characteristics (SPC)
UK

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 525501103111314
CA
Health Products and Food Branch
Identifier(s): 02245329
DE
Bundesinstitut für Arzneimittel und Medizinprodukte
Identifier(s): 00070182, 00461793, 01453666, 03221368, 03368829, 06435696, 07765088, 07765094, 07778547, 13248977, 16834724, 16834730
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 63955
FR
Base de données publique des médicaments
Identifier(s): 62158815
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 138810, 142401, 161819, 17233, 391355
HK
Department of Health Drug Office
Identifier(s): 49103
IE
Health Products Regulatory Authority
Identifier(s): 25828, 75210, 75219
NL
Z-Index G-Standaard, PRK
Identifier(s): 122416
SG
Health Sciences Authority
Identifier(s): 11446P
US
FDA, National Drug Code
Identifier(s): 0006-0031